Do you consider NSCLC with multistation N2 involvement appropriate for treatment with neoadjuvant chemoimmunotherapy followed by surgery?  

Answer from: Radiation Oncologist at Academic Institution
Radiation Oncologist at McLeod Regional Medical Center
This treatment paradigm is certainly exciting...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice